Rhein-Neckar Metropolitan Region
Clemens is an experienced fund manager & investor, an involved portfolio manager and board member. His focus is on breakthrough technologies, BioPharma, tech and growth companies as well as secondaries. Clemens holds a PhD in molecular biology from the German Cancer Research Center; 25 years in the Private Equity and Venture Capital industry.
Heidelberg Capital focuses on high-tech companies, proven business models, growth capital and small to mid-sized buyouts. The HeidelbergCapital team has a proven track record in portfolio management, active asset management, profit improvement, deleveraging, banking, and multiple expansion.